Loading company…
Riskpilot
← Back to search
Sign in
Get full access
Jangelind Consulting AB
AB
Dissolved
Org 5590433248
Wholesale of pharmaceutical and medical goods · NACE 4646
Est. 2015
0 employees
Watchlist
Share
Overview
Financials
People & ownership
Related companies
Revenue 2018
SEK 0
EBITDA margin
—
-134% vs 2017
Equity ratio
99.0%
Financial strength
Net profit 2018
SEK -15K
-158% vs 2017
EBITDA — year on year
SEK millions
0M
-0M
-1M
-1M
-1M
0M
2016
0M
0%
2017
0M
0%
2018
Key figures
Annual report 2018
Revenue
SEK 0
—
EBITDA
SEK -15K
-134%
Net profit
SEK -15K
-158%
Total assets
SEK 100K
-28%
Equity
SEK 99K
-13%
Employees
0
—
Company information
Legal name
Jangelind Consulting AB
Org number
5590433248
Legal form
Aktiebolag
NACE code
4646 · Wholesale of pharmaceutical and medical goods
Founded
21 december 2015
Share capital
SEK 0
Employees
0
VAT registered
No
Audit selected
No
Last report
2018-08-31
Financial year
January – December
Company purpose
Föremålet för bolagets verksamhet är att bedriva konsultationer inom läkemedelsindustrin och därmed förenlig verksamhet.
Contact
Address
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
Visit risika.com
Explore
Companies in Wholesale of pharmaceutical and medical goods
Companies in
All Sweden companies
Revenue
SEK millions
0M
0M
1M
1M
1M
1M
2016
0M
2017
0M
2018
EBITDA
SEK millions
0M
0M
1M
1M
1M
0M
2016
0M
2017
0M
2018
Income statement
SEK thousands
Item
2016
2017
2018
Revenue
734
444
0
Staff expenses
—
—
—
EBITDA
113
44
−15
Depreciation & amort.
−0
−10
−0
EBIT
113
34
−15
Net financials
—
—
—
Profit before tax
113
34
−15
Tax
−25
−8
−0
Net profit
88
26
−15
Balance sheet
SEK thousands
Item
2016
2017
2018
Total assets
388
138
100
Equity
138
114
99
Long-term debt
0
0
0
Short-term debt
250
24
1
Total debt
250
24
1
Financial ratios
5-year trend
EBITDA margin
-1500000.0%
This company
15.8%
Market median
-9493771% vs market
2016
2018
Equity ratio
99.0%
This company
38.2%
Market median
+159% vs market
2016
2018
Return on equity
-15.2%
This company
18.4%
Market median
-183% vs market
2016
2018
Net profit margin
-1500000.0%
This company
8.1%
Market median
-18518619% vs market
2016
2018
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2016
2018
Debt / equity
0.01×
This company
0.62×
Market median
+98% vs market
2016
2018
Annual reports & filings
Annual report 2018
Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
View
PDF
Annual report 2017
Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
View
PDF
Annual report 2016
Filed via Bolagsverket / SCB · Period 2015-12-01 – 2016-08-31
View
PDF
Management
Actively employed in the business
No data on file.
Board of directors
Non-executive oversight
Name
Role
Member since
Current (2)
LR
Leif Robert Hermansson
Deputy Board Member
2020
AM
Ann-Charlott Maria Hermansson
Board of Directors
2020
Shareholders
As of last annual report
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
Company hierarchy
No registered parent or subsidiaries
Board network connections
Board members of Jangelind Consulting AB also hold positions in
0
other companies.
Person
Role here
Other companies
Leif Robert Hermansson
Deputy Board Member
0 companies
Ann-Charlott Maria Hermansson
Board of Directors
0 companies